This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
Regulus Therapeutics Inc
RGLS : NASDAQ : Health Care
$18.57 1.13 | 6.48%
Today's Range: 17.42 - 18.64
Avg. Daily Volume: 1,567,300
11/26/14 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
RGLS REGULUS THERAPEUTICS INC 15.69 762.60 n/m 8.90 -48.69
AMAG AMAG PHARMACEUTICALS INC 35.59 900.61 n/m 92.84 15.63
IMGN IMMUNOGEN INC 9.68 831.86 n/m 55.88 14.83
ENTA ENANTA PHARMACEUTICALS INC 44.00 817.65 24.72 46.45 1532.79
EPZM EPIZYME INC 23.56 804.88 n/m 67.38 109.47
SGMO SANGAMO BIOSCIENCES INC 11.53 788.70 n/m 37.79 44.24
BCRX BIOCRYST PHARMACEUTICALS INC 10.35 743.79 n/m 18.73 72.37
MGNX MACROGENICS INC 26.10 725.45 n/m 57.23 182.85
OREX OREXIGEN THERAPEUTICS INC 5.76 709.44 n/m 33.43 875.14
INFI INFINITY PHARMACEUTICALS INC 14.21 692.98 n/m 160.64 n/a
FMI FOUNDATION MEDICINE INC 23.54 666.44 n/m 52.06 534.27
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

RGLS Ind Avg S&P 500
n/m 64.35 19.91
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs